[The effect of dalargin on the course of experimental cardiac arrhythmias]. 1994

T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina

Five models of arrhythmias (aconitine-, calcium chloride- and low-sodium-induced models on rats, coronary artery ligation and reperfusion in dogs) were used to study the antiarrhythmic and antifibrillatory effects. The latters were not inferior to those shown by the well-known antiarrhythmics. The mechanisms of the action of dalargin are discussed in the paper.

UI MeSH Term Description Entries
D008012 Lidocaine A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Lignocaine,2-(Diethylamino)-N-(2,6-Dimethylphenyl)Acetamide,2-2EtN-2MePhAcN,Dalcaine,Lidocaine Carbonate,Lidocaine Carbonate (2:1),Lidocaine Hydrocarbonate,Lidocaine Hydrochloride,Lidocaine Monoacetate,Lidocaine Monohydrochloride,Lidocaine Monohydrochloride, Monohydrate,Lidocaine Sulfate (1:1),Octocaine,Xylesthesin,Xylocaine,Xylocitin,Xyloneural
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D002122 Calcium Chloride A salt used to replenish calcium levels, as an acid-producing diuretic, and as an antidote for magnesium poisoning. Calcium Chloride Dihydrate,Calcium Chloride, Anhydrous
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D000157 Aconitine A C19 norditerpenoid alkaloid (DITERPENES) from the root of ACONITUM; DELPHINIUM and larkspurs. It activates VOLTAGE-GATED SODIUM CHANNELS. It has been used to induce ARRHYTHMIAS in experimental animals and it has anti-inflammatory and anti-neuralgic properties. Acetylbenzoylaconine,Aconitane-3,8,13,14,15-pentol, 20-ethyl-1,6,16-trimethoxy-4-(methoxymethyl)-, 8-acetate 14-benzoate, (1alpha,3alpha,6alpha,14alpha,15alpha,16beta)-,Acetylbenzoyl-aconine,Acetylbenzoyl aconine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic

Related Publications

T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
May 1993, Voenno-meditsinskii zhurnal,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
January 1986, Farmakologiia i toksikologiia,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
April 1961, Revue canadienne de biologie,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
January 1991, Kardiologiia,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
January 1982, Journal of cardiovascular pharmacology,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
January 1995, Likars'ka sprava,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
January 1992, Klinicheskaia khirurgiia,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
August 1996, Biulleten' eksperimental'noi biologii i meditsiny,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
March 1972, British journal of pharmacology,
T I Grekova, and K M Reznikov, and O V Vinokurova, and A A Kireeva, and T I Taratinova, and V A Nikolaevskiĭ, and N A Shchetinkina
January 1988, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
Copied contents to your clipboard!